Clinical and Cost Effectiveness of Positive Behaviour Support: a Trial (PBS)

May 20, 2016 updated by: University College, London

Clinical and Cost Effectiveness of Staff Training in Positive Behaviour Support (PBS) for Treating Challenging Behaviour in People With Intellectual Disability: A Cluster Randomised Controlled Trial

Many people with intellectual disability have challenging behaviour which often has serious consequences such as the prescription of long term medication, in-patient admissions and disruption of normal daily activities. Community intellectual disability services may have difficulties in helping people with challenging behavior. Available research suggests that Positive Behavior Support (PBS), a training system that teaches staff how to manage these situations, can benefit service users who may show improvements in challenging behavior and quality of life. The investigators do not know of any study so far that has examined the clinical and cost effectiveness of PBS that is provided by staff in routine clinical practice in community intellectual disability services. If PBS proved to be better than treatment as usual, it would have important implications for the management of a very vulnerable group of service users. In this trial, health staff will receive accredited training in PBS available in a manual written by PBS experts. It will give details of how to understand challenging behavior and develop a management plan and how to implement it and monitor whether it has achieved its goals. Twenty community intellectual disability services and 260 service users with mild to severe intellectual disability and challenging behavior will be invited to take part in the study. The sample size calculations are based on our pilot study and allow for non participation of 10% and inflation due to the number of community intellectual disability teams and staff that will take part. The teams will be randomly allocated into one of two conditions. Half will be in the PBS arm (but will also have treatment as usual) and half will be in the treatment as usual only group. The investigators will carry out assessments of challenging behavior, use of services, quality of life, mental health, aggression and family and paid carer burden at six and 12 months. The investigators will monitor treatment fidelity and the investigators will talk to a sample of paid and family carers, service users, staff and managers about what they think of the treatment and how best the investigators can deliver it in routine care. The main outcome is reduction in challenging behavior at one year after the randomization. The investigators will also carry out a health economic evaluation to examine the costs and consequences of staff training in PBS.

Study Overview

Detailed Description

Please see published protocol at:

http://www.biomedcentral.com/1471-244X/14/219

Study Type

Interventional

Enrollment (Actual)

246

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leicester, United Kingdom
        • Leicestershire Foundation Trust
      • London, United Kingdom
        • Camden & Islington Foundation Trust
      • London, United Kingdom
        • South London and St George's Mental Health Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Service users: Eligible to receive care from intellectual disability services; mild to severe intellectual disability; aged 18 years and over; total ABC score of at least 15 (indicates a degree of challenging behaviour occurring at least weekly including verbal or physical aggression, hyperactivity, refusal to attend activities, non responsiveness that requires professional input).
  • Service: Willing to participate; availability of at least two staff members willing to train; written agreement by the service manager to participate.

Exclusion Criteria:

  • Service users: primary clinical diagnosis of personality disorder or substance misuse; relapse in pre-existing mental disorder; decision by clinical team that a referral to the study would be inappropriate, e.g. there is an open complaint investigation
  • Service: there are no team members willing to train; the service has already received and implements accredited PBS for their service users.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: PBS based staff training

The training, which will be supported by a treatment manual will comprise the following sections:

  1. Functional Behavioural Assessment and formulation skills

    • Brief Behavioural Assessment Tool for brief functional analyses

  2. Primary Prevention
  3. Secondary Prevention and Reactive Strategies
  4. Periodic Service Review and Problem Solving

    • Developing individualised periodic service reviews
    • Trouble shooting

Please see published study protocol for more information:

http://www.biomedcentral.com/1471-244X/14/219

http://www.biomedcentral.com/1471-244X/14/219
OTHER: Treatment as usual
Most community intellectual disability services provide a range of health interventions that include but are not limited to psychiatric assessment and management, nursing support, psychology, speech and language therapy, occupational therapy and counselling. There may be some variation in resources but service users with challenging behaviour are likely to receive a range of broadly defined behavioural management and pharmacological interventions. Staff is routinely supervised by their clinical managers weekly.
http://www.biomedcentral.com/1471-244X/14/219

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Challenging Behaviour
Time Frame: 12 months
Reduction in challenging behaviour as measured by the Aberrant Behaviour Checklist (ABC)and change from baseline and 6 months
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life
Time Frame: 12 months
Improvement in Quality of Life measured by the Quality of Life Questionnaire
12 months
Mental health status
Time Frame: 12 months
Improvement in mental health measured by the mini-PASADD.
12 months
Family carer burden
Time Frame: 12 months
Reduction in family carer burden measured by the Uplift/Burden Scale
12 months
Paid carer burden
Time Frame: 12 months
Reduction in burden measured by Caregiving Difficulty Scale-Intellectual Disability
12 months
Family Carer Psychiatric Morbidity
Time Frame: 12 months
Reduction in Psychiatric morbidity measured by the General Health Questionnaire (12 item version)
12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cost effectiveness
Time Frame: 12 months
Service use will be measured over the trial period at three month intervals using the Client Service Receipt Inventory adapted specifically for the study
12 months
Community participation
Time Frame: 6 months
Improvement measured by change in Guernsey Community Participation and Leisure Activity Scale (GCPLAS)
6 months
Community participation
Time Frame: 12 months
Positive change from 6 months as measured with the GCPLAS
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Andre Strydom, MD PhD, UCL
  • Study Director: Ian Hall, MBBS MPhil, East London Foundation Trust
  • Study Director: Michael King, FRCGP PhD, UCL
  • Study Director: Rumana Omar, UCL Statistics
  • Study Director: Rachael Hunter, Health Economist
  • Study Director: Vivien Cooper, Challenging Behaviour Foundation

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2012

Primary Completion (ACTUAL)

November 1, 2015

Study Completion (ANTICIPATED)

November 1, 2016

Study Registration Dates

First Submitted

August 28, 2012

First Submitted That Met QC Criteria

September 3, 2012

First Posted (ESTIMATE)

September 7, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

May 23, 2016

Last Update Submitted That Met QC Criteria

May 20, 2016

Last Verified

June 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Challenging Behaviour

Clinical Trials on PBS based staff training

Subscribe